HOWL
HOWL
NASDAQ · Biotechnology

Werewolf Therapeutics Inc

$0.68
+0.06 (+9.68%)
As of May 16, 2:24 AM ET ·
Financial Highlights (FY 2026)
Revenue
2.73M
Net Income
-102,176,432
Gross Margin
Profit Margin
-3,740.9%
Rev Growth
D/E Ratio
0.36
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 35.6% 35.6% 35.6%
Operating Margin -3,933.5% 15.3% 18.3% 15.2%
Profit Margin -3,740.9% 18.5% 14.0% 18.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.73M 5.14M 4.74M 5.21M
Gross Profit 1.83M 1.69M 1.86M
Operating Income -107,437,212 783.4K 865.5K 791.8K
Net Income -102,176,432 951.6K 665.5K 945.6K
Gross Margin 35.6% 35.6% 35.6%
Operating Margin -3,933.5% 15.3% 18.3% 15.2%
Profit Margin -3,740.9% 18.5% 14.0% 18.1%
Rev Growth -9.9% +8.5% -0.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.43M 2.67M 2.50M 2.38M
Total Equity 18.08M 23.33M 23.90M 24.74M
D/E Ratio 0.36 0.11 0.10 0.10
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -102,471,540 1.31M 1.24M 1.40M
Free Cash Flow 380.5K 530.0K 488.3K